Please use this identifier to cite or link to this item: http://hdl.handle.net/10397/91425
PIRA download icon_1.1View/Download Full Text
DC FieldValueLanguage
dc.contributorSchool of Nursing-
dc.creatorChan, CWen_US
dc.creatorMolassiotis, Aen_US
dc.creatorLee, HKKen_US
dc.date.accessioned2021-11-03T06:53:33Z-
dc.date.available2021-11-03T06:53:33Z-
dc.identifier.issn0941-4355en_US
dc.identifier.urihttp://hdl.handle.net/10397/91425-
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.rights© The Author(s) 2021en_US
dc.rightsOpen Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.en_US
dc.rightsThe following publication Chan, C.W., Molassiotis, A. & Lee, H.K.K. Antimicrobial prophylaxis and post-chemotherapy neutropenic fever in patients with leukemia: comparisons of C-reactive protein, procalcitonin and immediate fever outcome measures between those with and without prophylaxis, and the implications for practice. Support Care Cancer (2021) is available at https://doi.org/10.1007/s00520-021-06325-3en_US
dc.subjectAntibiotic or antifungal prophylaxisen_US
dc.subjectC-reactive proteinen_US
dc.subjectLeukemiaen_US
dc.subjectPost-chemotherapy neutropenic feveren_US
dc.subjectProcalcitoninen_US
dc.subjectRisk–benefit of prophylaxisen_US
dc.titleAntimicrobial prophylaxis and post-chemotherapy neutropenic fever in patients with leukemia : comparisons of C-reactive protein, procalcitonin and immediate fever outcome measures between those with and without prophylaxis, and the implications for practiceen_US
dc.typeJournal/Magazine Articleen_US
dc.identifier.doi10.1007/s00520-021-06325-3en_US
dcterms.abstractPurpose: The efficacy of prophylactic antimicrobial treatment renders challenges in patients with leukemias receiving chemotherapy. The study aimed to compare differences in C-reactive protein (CRP) and procalcitonin (PCT) at presentation and the immediate outcome measures of post-chemotherapy NF between patients with and without antimicrobial prophylaxis.-
dcterms.abstractMethods: A 5-year observational study included 282 NF episodes in 133 leukemia patients requiring hospital care from January 2014 to May 2019. We collected demographic characteristics, laboratory data of blood cell counts and inflammatory biomarkers, and immediate outcome measures of NF, including microbiologically diagnosed infections, presence of predominant pathogens, required modification of antibiotics during NF, adverse medical complications, total fever duration, and deaths. We evaluated data between patients with and without prophylaxis.-
dcterms.abstractResults: Of patients, 77.3%, 68.4%, and 20.6% had antibiotic prophylaxis, antifungal prophylaxis, and no prophylaxis, respectively. There were totally 15 deaths—13 with antibiotic prophylaxis and 10 with antifungal prophylaxis. CRP, PCT, and immediate outcome measures of NF did not show significant differences between those with and without antimicrobial prophylaxis. Although between-group differences showed no statistical significance, higher median fever duration, CRP and PTC values, and higher proportions of NF requiring modification of antibiotics were found more frequently in those with antimicrobial prophylaxis than in those without.-
dcterms.abstractConclusion: The benefits of using antimicrobial prophylaxis were less supported. Enhancing diagnostic laboratory and medical complication surveillance and periodic evaluation of institutional data during post-chemotherapy neutropenia and NF in relation to antimicrobial prophylaxis is promising in providing insights to redefine the risk–benefit accounts of using prophylaxis.-
dcterms.accessRightsopen accessen_US
dcterms.bibliographicCitationSupportive care in cancer, 2021, Online first, https://doi.org/10.1007/s00520-021-06325-3en_US
dcterms.isPartOfSupportive care in canceren_US
dcterms.issued2021-
dc.identifier.scopus2-s2.0-85107750298-
dc.identifier.eissn1433-7339en_US
dc.description.validate202110 bcvc-
dc.description.oaVersion of Recorden_US
dc.identifier.FolderNumberOA_Scopus/WOS-
dc.description.pubStatusEarly releaseen_US
Appears in Collections:Journal/Magazine Article
Files in This Item:
File Description SizeFormat 
Chan_Antimicrobial_Post_Chemotherapy.pdf567.65 kBAdobe PDFView/Open
Open Access Information
Status open access
File Version Version of Record
Access
View full-text via PolyU eLinks SFX Query
Show simple item record

Page views

7
Citations as of Jul 3, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.